These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
461 related items for PubMed ID: 18201301
21. Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections. Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Mulleners WM, Munneke M. Parkinsonism Relat Disord; 2007 Dec; 13(8):532-4. PubMed ID: 17383926 [Abstract] [Full Text] [Related]
22. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy. Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA. Dev Med Child Neurol; 2020 Jul; 62(7):861-867. PubMed ID: 32149393 [Abstract] [Full Text] [Related]
23. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Erasmus CE, Van Hulst K, Rotteveel LJ, Jongerius PH, Van Den Hoogen FJ, Roeleveld N, Rotteveel JJ. Dev Med Child Neurol; 2009 Jun; 51(6):454-9. PubMed ID: 19207297 [Abstract] [Full Text] [Related]
24. Does motor performance matter in botulinum toxin efficacy for drooling? Erasmus CE, Scheffer AR, van Hulst K, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH. Pediatr Neurol; 2011 Aug; 45(2):95-9. PubMed ID: 21763949 [Abstract] [Full Text] [Related]
25. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures. Erasmus CE, van Hulst K, Scheffer AR, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH. Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393 [Abstract] [Full Text] [Related]
26. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C. Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273 [Abstract] [Full Text] [Related]
28. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Savarese R, Diamond M, Elovic E, Millis SR. Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333 [Abstract] [Full Text] [Related]
29. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study. Hay N, Penn C. Int J Lang Commun Disord; 2011 Apr; 46(5):550-63. PubMed ID: 21899672 [Abstract] [Full Text] [Related]
30. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions. Khan A, Pawar G. W V Med J; 2005 Apr; 101(6):258-60. PubMed ID: 16625812 [Abstract] [Full Text] [Related]
31. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease? Nóbrega AC, Rodrigues B, Torres AC, Enzo A, Melo A. J Neurol Sci; 2007 Feb 15; 253(1-2):85-7. PubMed ID: 17229441 [Abstract] [Full Text] [Related]
37. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG. Mov Disord; 2006 May 15; 21(5):704-7. PubMed ID: 16440332 [Abstract] [Full Text] [Related]
38. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Fuster Torres MA, Berini Aytés L, Gay Escoda C. Med Oral Patol Oral Cir Bucal; 2007 Nov 01; 12(7):E511-7. PubMed ID: 17978775 [Abstract] [Full Text] [Related]